Abstract
Background: Brain tumors represent a unique, heterogenous population of neoplasms that include both benign and malignant tumors. International data depict that tumors of central nervous system account for 1- 2% of all neoplasm. This study was designed to assess the histopathologic spectrum of glial tumors in Indian population which will guide the clinicians to establish measures for an improved diagnosis and management protocols including the use of targeted chemotherapy for specific subtypes.
Method: 117 cases of glial tumors who underwent neurosurgery for space occupying lesions of the brain were enrolled. After gross examination routine histological sections were made using haematoxylin and eosin stains. The diagnosis and grading were done according to WHO classification of CNS tumors.
Result: Most common age of presentation of glial tumours was 31 -45 yrs age group (41%) followed by 46 -60 yrs (30.7%). Males were affected more commonly with sex ratio of 1.9:1. Astrocytomas were the most common glial tumours in our population with grade II astrocytoma being most common followed by grade III tumours.
Conclusion: Among 117 cases which were analysed; 87 were Astrocytomas, 11 were Ependymoma, 12 were glioblastoma multiforme and 7 were oligodendroglioma. The knowledge of histopathologic spectrum of glial tumors in our population will guide the clinicians to establish measures for an improved diagnosis and management protocols.
References
Central Brain Tumor Registry of the United States. Source for incidence and mortality data: Surveillance, Epidemiology, and End Results (SEER) Program and the National Center for Health Statistics. United States: National center for health statistics; Available from: http://www.cbtrus.org/factsheet/factsheet.html.
Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005; 55:74-108.
Kanthikar SN, Nikumbh DB, Dravid NV. Histopathological overview of central nervous system tumors in North Maharashtra, India: a single center study. Indian Journal of Pathology and Oncology, January-March 2017;4(1):80.
Dasgupta A, Gupta T, Jalali R. Indian data on central nervous tumors: A summary of published work. South Asian J Cancer. 2016; 5:147-53.
Hashmi AA, Faridi N, Malik B, Edhi MM, Khurshid A, Khan M. Morphologic spectrum of glial tumors: an increased trend towards oligodendroglial tumors in Pakistan. Int Arch Med. 2014; 7: 33.
Jalali R, Datta D: Prospective analysis of incidence of central nervous system tumors presenting in a tertiary cancer hospital from India. J Neurooncol 2008; 87: 111-4.
Chawla N, Kataria SP, Malik S, Sharma N, Kumar S. Histopathological spectrum of cns tumours in a tertiary care referral centre - a one-year study. Int J App Basic Med Res. May-Aug 2014; 4: 141-5.
Quinn T. Ostrom, Luc Bauchet, Faith G. Davisret. The epidemiology of glioma in adults: a "state of the science" review. Neuro-Oncology. 2015;17(4): 623-4.
Dubrow R, Darefsky AS: demographic variation in incidence of adult glioma by subtype, United States,1992-2007. BMC Cancer. 2011; 11:325.
Trabelsi S, Brahim DH, Ladib M, et al. Glioma epidemiology in the central Tunisian population: 1993-2012. Asian Pac J Cancer Prev. 2014;15(20):8753-7.
Ahmed Z, Azad NS, Muzaffer S, Hasan SH. CNS tumors at AKU: an update plus a brief discussion on intraventricular tumors with special emphasis on central neurocytoma. J Ayub Med Coll Abbott. 2004;16(4):12-5.
Narmada R, Dhanalakshmi SP, Priyadharshni M et al. Histomor-phological study of CNS tumours - a 3-year retrospective descriptive study in a tertiary care center. J Evolution med. Dent. Sci 2017;6(43); 3362 -6.
How to cite this article:
Karnwal B, Sharma RL, Jain R and Jain B. Morphological Spectrum of Glial Tumors in J.A. Group of Hospitals, G.R. Medical College, Gwalior. Int. J. Res. Dev. Pharm. L. Sci. 2018; 7(3): 3011-3014. doi: 10.13040/IJRDPL.2278-0238.7(3).3011-3014
This Journal is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Copyright (c) 2020 Array